INK4a-ARF Mutations in Skin Carcinomas from UV Irradiated Hairless Mice

Molecular Carcinogenesis

Volumn 39, Issue 4, 2004, Pages 195-198

  Soufir, N ^a   Queille, S ^b   Mollier, K ^a   Roux, E ^b   Sarasin, A ^b   De Gruijl, F R ^c   Fourtanier, A M ^d   Daya Grosjean, L ^b   Basset Seguin, N ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CNRS/IGR   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d L ORÉAL RECHERCHE   (France)

Author keywords

Hairless mice; Ink4a ARF; Mutagenesis; Skin cancer; UV

Indexed keywords

PROTEIN INK4A ARF; PROTEIN MDM2; PROTEIN P14ARF; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE; GENE LOCUS; INK4A ARF GENE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; GENES, P16; MICE; MICE, INBRED HRS; MUTATION; NEOPLASMS, RADIATION-INDUCED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PRECANCEROUS CONDITIONS; PYRIMIDINES; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 1842533484     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20004     Document Type: Article

References (25)

1. van Kranen HJ, de Gruijl FR. Mutations in cancer genes of UV-induced skin tumors of hairless mice. J Epidemiol 1999;9:S58-S65.
2. Berg RJ, de Gruijl FR, van der Leun JC. Interaction between ultraviolet A and ultraviolet B radiations in skin cancer induction in hairless mice. Cancer Res 1993;53:4212-4217.
3. Rebel H, Mosnier LO, Berg RJ, Westerman-de Vries A, van Steeg H, van Kranen HJ, de Gruijl FR. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: Kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res 2001;61:977-983.
4. de Gruijl FR, Forbes PD. UV-induced skin cancer in a hairless mouse model. Bioessays 1995;17:651-660.
5. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993;90:10529-10533.
6. Queille S, Seite S, Tison S, Medaisko C, Drougard C, Fourtanier A, Sarasin A, Daya-Grosjean L. p53 mutations in cutaneous lesions induced in the hairless mouse by a solar ultraviolet light simulator. Mol Carcinog 1998;22:167-174.
7. Dumaz N, van Kranen HJ, de Vries A, Berg RJ, Wester PW, van Kreijl CF, Sarasin A, Daya-Grosjean L, de Gruijl FR. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis 1997;18:897-904.
8. Basset-Seguin N, Moles JP, Mils V, Dereure O, Guilhou JJ. TP53 tumor suppressor gene and skin carcinogenesis. J Invest Dermatol 1994;103:102S-106S.
9. Sherr CJ, Weber JD. The ARF/p53 pathway. Curr Opin Genet Dev 2000;10:94-99.
10. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000;2:148-155.
11. Kubo Y, Urano Y, Matsumoto K,Ahsan K, Arase S. Mutations of the INK4a locus in squamous cell carcinomas of human skin. Biochem Biophys Res Commun 1997;232:38-41.
12. Soufir N, Moles JP, Vilmer C, Moch C, Verola O, Rivet J, Tesniere A, Dubertret L, Basset-Seguin N. P16 UV mutations in human skin epithelial tumors. Oncogene 1999;18:5477-5481.
13. Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N. Association between INK4a-ARFand p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 2000;92:1841-1847.
14. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 1993;53:1625-1629.
15. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998;1378:F115-F177.
16. Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis 1998;19:1045-1052.
17. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. Tumor spectrum in ARF-deficient mice. Cancer Res 1999;59:2217-2222.
18. Sherr CJ. Parsing Ink4a/Arf: "Pure" p16-null mice. Cell 2001;106:531-534.
19. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA. Loss of p16Ink4a with retention of pl 9Arf predisposes mice to tumorigenesis. Nature 2001;413:86-91.
20. Orlow I, Rabbani F, Chin L, Pomerantz J, Ligeois N, Dudas M, Depinho R, Cordon-Cardo C. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Int J Oncol 1999;15:17-24.
21. Enders GH, Koh J, Missero C, Rustgi AK, Harlow E. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene 1996;12:1239-1245.
22. Munro J, Stott FJ, Vousden KH, Peters G, Parkinson EK. Role of the alternative INK4A proteins in human keratinocyte senescence: Evidence for the specific inactivation of p 16INK4A upon immortalization. Cancer Res 1999;59:2516-2521.
23. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res 1995;55:5168-5172.
24. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types [see comments]. Science 1994;264:436-440.
25. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41, in melanoma. Cancer Res 1994;54:5269-5272.